Loomis, Sayles & Company’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-36
| Closed | -$3K | – | 1004 |
|
|
2023
Q2 | $3K | Sell |
36
-99
| -73% | -$8.67K | ﹤0.01% | 927 |
|
|
2023
Q1 | $12K | Buy |
+135
| New | +$11.7K | ﹤0.01% | 805 |
|
|
2022
Q2 | – | Sell |
-42
| Closed | -$5K | – | 1035 |
|
|
2022
Q1 | $5K | Buy |
+42
| New | +$4.48K | ﹤0.01% | 799 |
|
|
2021
Q4 | – | Sell |
-174
| Closed | -$25K | – | 876 |
|
|
2021
Q3 | $25K | Buy |
174
+93
| +115% | +$12.5K | ﹤0.01% | 658 |
|
|
2021
Q2 | $10K | Hold |
81
| – | – | ﹤0.01% | 780 |
|
|
2021
Q1 | $10K | Sell |
81
-19,031
| -100% | -$3.51M | ﹤0.01% | 788 |
|
|
2020
Q4 | $3.43M | Sell |
19,112
-18,297
| -49% | -$4.07M | ﹤0.01% | 430 |
|
|
2020
Q3 | $8.21M | Sell |
37,409
-325,269
| -90% | -$72.6M | 0.01% | 356 |
|
|
2020
Q2 | $81.1M | Sell |
362,678
-161,557
| -31% | -$25.3M | 0.13% | 69 |
|
|
2020
Q1 | $51.3M | Buy |
524,235
+25,218
| +5% | +$2.04M | 0.11% | 76 |
|
|
2019
Q4 | $37.4M | Sell |
499,017
-7,588
| -1% | -$490K | 0.06% | 118 |
|
|
2019
Q3 | $31.1M | Buy |
506,605
+344,732
| +213% | +$20.7M | 0.06% | 139 |
|
|
2019
Q2 | $9.6M | Sell |
161,873
-2,751
| -2% | -$165K | 0.02% | 353 |
|
|
2019
Q1 | $10.8M | Sell |
164,624
-36,666
| -18% | -$2.22M | 0.02% | 337 |
|
|
2018
Q4 | $9.83M | Sell |
201,290
-913
| -0.5% | -$54.5K | 0.02% | 322 |
|
|
2018
Q3 | $13.2M | Sell |
202,203
-28,666
| -12% | -$2M | 0.03% | 315 |
|
|
2018
Q2 | $15.4M | Sell |
230,869
-32,932
| -12% | -$1.99M | 0.03% | 311 |
|
|
2018
Q1 | $13.7M | Buy |
263,801
+2,519
| +1% | +$117K | 0.03% | 345 |
|
|
2017
Q4 | $11.3M | Buy |
+261,282
| New | +$10.7M | 0.02% | 407 |
|
|
2015
Q4 | – | Sell |
-574,027
| Closed | -$10.8M | – | 1104 |
|
|
2015
Q3 | $10.8M | Sell |
574,027
-87,703
| -13% | -$1.88M | 0.03% | 419 |
|
|
2015
Q2 | $15.2M | Buy |
661,730
+23,634
| +4% | +$550K | 0.04% | 400 |
|
|
2015
Q1 | $17.2M | Buy |
638,096
+12,117
| +2% | +$309K | 0.05% | 377 |
|
|
2014
Q4 | $18.1M | Sell |
625,979
-31,746
| -5% | -$860K | 0.05% | 369 |
|
|
2014
Q3 | $17.7M | Sell |
657,725
-17,398
| -3% | -$415K | 0.05% | 364 |
|
|
2014
Q2 | $14.9M | Sell |
675,123
-24,826
| -4% | -$571K | 0.04% | 441 |
|
|
2014
Q1 | $19.1M | Sell |
699,949
-3,333
| -0.5% | -$97.2K | 0.05% | 366 |
|
|
2013
Q4 | $21.7M | Buy |
703,282
+73,029
| +12% | +$1.87M | 0.07% | 322 |
|
|
2013
Q3 | $17.9M | Buy |
+630,253
| New | +$17.2M | 0.06% | 370 |
|
Other funds holding QDEL
CG
SM
ACH
BAM
Loomis, Sayles & Company's QDEL Position: Q3 2023 in Review
Loomis, Sayles & Company sold out of QuidelOrtho (QDEL) in Q3 2023, closing a stake of 36 shares — an estimated $3K sold.
Loomis, Sayles & Company first reported a position in QDEL in Q3 2013 and held it in 28 quarters. The position peaked at $81.1M in Q2 2020. 304 funds tracked by Wall St. Rank hold QDEL as of Q3 2023.
- Loomis, Sayles & Company reported no remaining QuidelOrtho position as of Q3 2023 after selling out during the quarter.
- Loomis, Sayles & Company sold 36 QuidelOrtho shares in Q3 2023, an estimated $3K.
- Loomis, Sayles & Company first reported a position in QuidelOrtho in Q3 2013 and held it in 28 quarters.
- Loomis, Sayles & Company's QuidelOrtho position peaked at $81.1M in Q2 2020.
- 304 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2023.
Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.